Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- Dongjin Road, Port Industry Area, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China (CHN)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3003404148 · DUNS 421324417
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-08-29
- NAIDrug Quality Assurance2015-08-24
Drugs this plant is listed as making
5 distinct drugs across 12 products name this site in their FDA label.
- BupivacaineJiangsu Hengrui Pharmaceuticals Co., Ltd.
- Dexmedetomidine Hydrochloride In 0.9% Sodium Chloridein shortageSandoz Inc.
- Fondaparinux SodiumSandoz Inc.
- GadobutrolFresenius Kabi USA, LLC
- gadoterate meglumineFresenius Kabi USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.